Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
Immune engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications
Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications
T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
2020 TCWP